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Introduction
Oxygen is a colourless, odourless and tasteless chemical element 
(O). As a therapeutic intervention it is the diatomic molecule, 
dioxygen (O2), that is commonly referred to as oxygen; the name itself 
a misnomer. O2 is present as 20.8% of the volume of air, it is essential 
for cell metabolism in all humans and most forms of life.
Oxygen’s image, together with its reputation, is changing. No 
longer is it regarded as a benign panacea for all clinical presentations; 
indeed it is now increasingly evident that oxygen has the potential 
to contribute to clinical deterioration and mortality. But it’s not all 
bad press; in a patient with hypoxaemia or sudden collapse oxygen is 
still one of the principle treatments, without which emergency care 
would be primitive. Yet misinformation, misunderstanding, and 
misplaced beliefs regarding oxygen therapy in clinical practice appear 
to flourish [1]. This non-systematic review has attempted to highlight 
the historical context of oxygen, contemporary issues related to its 
use, and some of the emerging evidence base that has contributed to 
a paradigm shift in the use of emergency oxygen therapy.
Historical Context and Contemporary Issues
It is interesting to note that caution regarding the use of oxygen 
therapy isn’t new; indeed it has been surrounded by contradiction 
and controversy since its discovery in the late 18th century. The first 
reference to the potential detrimental effects of too much oxygen was 
made by Joseph Priestly himself in 1774 [2], who warned that in the 
presence of oxygen that:
“as a candle burns out much faster in [oxygen] than in common 
air, so we might, as may be said, live out too fast ... the air which nature 
has provided for us is as good as we deserve”.
In this citation Priestley seems to be referring to the potential 
toxicity of oxygen dependant on its concentration, and the fact that 
the oxygen level provided in atmospheric air is sufficient for health 
and sustaining life.
In 1849 Lorrain Smith [3] next recognised oxygen’s potentially 
noxious qualities. Smith reported in animal studies that high oxygen 
tensions act as an irritant, inflaming lung tissue. Advances in 
physiological understanding were furthered by John Scott Haldane 
in 1917 [4], when he identified the regulation of the respiratory drive 
by carbon dioxide and its effects on blood pH and outlined the need 
for rational use of oxygen. Haldane’s cautious advice was to give 
only as much oxygen as would ‘suffice to relieve anoxaemia’ [4]. 
This recognition of judicious employment of oxygen remains a key 
message in today’s guidelines [1].
Experimental work by Meakins in 1920 outlined methods for 
calculating percentage of oxygen saturation of haemoglobin and its 
relationship to the patient’s condition [5]. setting the scene for the 
clinical application of the physiological discoveries of the early 20th 
century.
Juxtaposition to these warnings regarding cautious 
administration of oxygen was the widespread introduction of the 
use of 100% oxygen therapy for most acute clinical presentations. 
The ability to administer high flow oxygen economically, efficiently 
and comfortably was widely endorsed [6] and although claims were 
cautioned by those aware of oxygen toxicity, current practice suggests 
this caveat was seldom heeded and the practice of administrating 
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high flow oxygen to treat most clinical presentations was established 
and persists today [7,8].
Given the frequency of its use in clinical interventions, there 
is widespread potential for the misuse of oxygen therapy. For 
example one UK audit of oxygen use in ambulances recorded use 
in 34% of patients [7]. For patients with conditions such as COPD 
(Chronic Obstructive Pulmonary Disease), this prevalence rises to 
82% in the emergency department [9]. A further audit found that 
88.7% of oxygen administered to patients presenting with an acute 
exacerbation of COPD in the pre-hospital setting was ‘inappropriate’ 
[10]. This seems unsurprising given that the most common reason 
cited for the administration of emergency oxygen in the acute clinical 
setting is not hypoxemia but shortness of breath [9].
There is an emerging cognisance that oxygen should be used 
with caution, and oxygen is regarded as a drug when administered 
as a therapeutic intervention [11]. Contemporary guidelines offer 
criteria and directives for administration and prescription of oxygen, 
dependant on the patient’s condition, acuity and care setting [1,12-
14]. Guidelines generally suggest that oxygen should be prescribed 
for hypoxaemia, as either an acute or chronic therapy; the condition 
being treated normally determining the concentration and duration 
of oxygen administered. Yet despite these widely accepted guidelines 
it is evident that poor practice persists [1,15-17]. The reasons why this 
may be the case remains elusive, but conjecture implies an ingrained 
culture of ‘more is better’ [15] and a belief that oxygen alleviates 
breathlessness [1].
Can Oxygen Therapy Harm?
It has long been established that oxygen can be toxic to the 
body; evolutionary processes have resulted in the development of 
protective measures to defend against hyperoxic damage. The ability 
to harness oxygen as a fuel was developed through the acquisition 
of mitochondria, which are the inherited legacy from photosynthetic 
ancestors [18]. The appearance of oxygen in Earth’s atmosphere 
allowed the highly efficient recovery of energy through aerobic 
respiration allowing oxygen to be harnessed as an economic fuel [19]. 
This then further supported the evolution of complex organisms with 
high energy demands.
Paradoxically the adaptation to aerobic respiration required 
additional adjustment to offer protection against the toxic effects of 
oxygen. The structure of the mitochondria themselves seems central 
to this protection; it is thought that the primary evolutionary function 
of compartmentalisation of mitochondria is to protect the cells’ nuclei 
from the damaging toxic side effects of oxygen metabolism [20].
Oxygen toxicity arises from oxygen’s tendency to radicalise, 
forming incompletely reduced free radicals also known as reactive 
oxygen species (ROS). ROS can be regarded as unstable molecules 
produced during normal metabolism that can, in excess, be damaging. 
An excess of ROS results in oxidative stress.
Not all free radicals are detrimental and some have important roles 
such as cell signalling, homeostasis and defence mechanisms such as 
phagocytosis [19]. The presence of free radicals then is essential to 
normal metabolism and their presence must be tolerated, an anti-
oxidant defence system is one way that the body prevents free radical 
damage [21]. It is these complex metabolic processes that maintain a 
fine balance in health but which pathological disease states can often 
tip. When this balance is upset, cumulative oxidative stress at cellular 
level can cause genetic degeneration and physiological dysfunction 
leading to progressive aging of a cell and cell death [22].
Although still not fully understood it is now generally accepted 
that living organisms have evolved to not only utilise oxygen but 
also to protect themselves from the potential damaging side-effects 
[19,21,22]. The sensitive equilibrium that the mitochondria aim to 
achieve is to keep the cellular oxygen concentration high enough to 
meet the tissue’s demands but low enough to minimise or control 
ROS formation.
Cytotoxic levels of ROS caused by hyperoxygenation are thought 
to be detrimental to metabolism and cause damage at cellular level 
[23]. When an excess of ROS or a depletion of antioxidants occurs 
oxidative stress results, causing damage and cell injury. These 
free radicals in excess are known to cause mutations and cancers 
through damage to DNA and protein, and lipid damage causes 
loss of functionality and an excess of toxic by-products in the cells. 
They are implicated in inflammation; carcinogenesis; ischeamia-
reperfusion injury; atherosclerosis; aging and death [24]. Seemingly 
the evolutionary irony of oxygen is that in addition to sustaining life 
it is also what limits lifespan and ultimately kills.
The Danger of Oxygen during Emergency Therapy
For several decades now it has been recognised that oxygen 
administration can cause significant increases in CO2 levels that can 
be detrimental to some patients, particularly those with hypercapnic 
respiratory failure [25]. Advice was proffered by Campbell in 1960 
who advocated small increments of oxygen to correct hypoxaemia in 
order to avoid the risk of worsening hypercapnia [26], referring to 
the need for ‘care and precision’ rather than ‘haphazard and imprecise 
dosage’.
In 1962 the detrimental effects of withdrawing oxygen abruptly 
from patients with hypercapnic respiratory failure was highlighted, 
cautioning that such practice could worsen hypoxia and hypercapnia 
and further lower pH. This finding further supported a growing 
consensus that continuous administration of low flow oxygen with 
graded increases avoids deterioration of respiratory failure whilst 
maintaining acceptable oxygen tensions [27]. This philosophy still 
underpins contemporary emergency oxygen guidelines [1].
Further evidence advocating judicious use of oxygen therapy was 
published in 1964 [28], suggesting that an arterial oxygen tension of 
50 mmHg (7kPa) would prevent death from hypoxia in patients with 
respiratory failure. The use of arterial blood gases was promoted to 
distinguish breathlessness from hypoxaemia, and, recognising the 
dangers of hypoxaemia over hypercapnia, advice was given never to 
withdraw oxygen completely.
The importance of titrating oxygen to achieve target saturation 
ranges has become increasingly apparent, with a number of 
randomised controlled trials indicating that failure to do so, instead 
over-oxygenating patients presenting with respiratory conditions, 
can lead to life threatening, if not fatal, respiratory acidosis [15,29-
31].
The acidosis resulting from injudicious use of oxygen, often in the 
pre-hospital setting, has been attributed to a number of mechanisms 
[1] arguably one of the most important being that of hypoxic 
pulmonary vasoconstriction. When ‘at risk’ individuals, namely those 
with hypercapnic respiratory failure, are administered with high 
flow oxygen, release of hypoxic pulmonary vasoconstriction occurs, 
resulting in reduced pulmonary arterial pressure and worsening of 
ventilation perfusion matching. A mismatch is then created, resulting 
in increased dead space, further hypercapnia and respiratory acidosis. 
Other risks to patients receiving excessive oxygen include absorption 
atelectasis, reduced cardiac output, damage from oxygen free radicals 
and increased systemic vascular resistance [1].
The evidence is now accumulating for the detrimental use of high 
flow oxygen and hyperoxaemia in patients with acute respiratory 
presentations. Austin [15] in a randomised controlled trial assessed 
the effect of high flow versus titrated O2 on mortality in a population 
of presumed COPD patients with an acute exacerbation in the 
prehospital setting in Tasmania. Overall mortality was 9% (21 deaths) 
in the high flow arm compared with 4% (7 deaths) in the titrated arm. 
In a sub group of patients with confirmed COPD the mortality was 
9% (11 deaths) in the high flow arm compared with 2% (2 deaths) in 
the titrated arm. This represented a reduced mortality of 58% for all 
patients and 78% for patients with confirmed COPD.
The dangers of injudicious use of oxygen therapy for patients 
with a respiratory condition are not restricted to those with COPD. 
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For example a New Zealand study recorded the effect of high 
concentration oxygen therapy on asthma patients in the emergency 
department [29]. Through transcutaneous monitoring of CO2 (PtCO2) 
blood levels, the researchers set out to estimate the proportion of 
patients with a clinically significant rise in PtCO2. In patients in the 
high concentration oxygen group the rise in PtCO2 of ≥ 4mm Hg at 
60 minutes was 44% versus 19% in the titrated arm. This supports the 
use of titrated oxygen in patients presenting with acute severe asthma 
rather than the traditional high flow administration.
There is also evidence that those with suspected CAP (community 
acquired pneumonia) will be endangered through the use of high 
concentration oxygen therapy. In one randomised study, 50% of those 
receiving it showed a clinically significant rise in PtCO2 50% which 
compares with 14.7% of those in the titrated arm [30]. Amongst the 
patients with confirmed CAP (radiological confirmation) the PtCO2 
rise affected 57.1% (high flow) versus 12.8% (titrated). This suggests 
that any respiratory disorder with abnormal gas exchange risks 
increasing hypercapnia with high concentrations of oxygen. In OHS 
(obesity hypoventilation syndrome) a similar message supports the 
use of oxygen titrated to saturations. Hollier et al [31] in a double 
blind randomised crossover study demonstrated that breathing 
moderate concentration of supplemental oxygen in stable OHS 
worsened hypercapnia and induced acideamia.
The dangers of inappropriate use of high concentration oxygen 
therapy are not restricted to patients with respiratory conditions. 
Indeed recent debate in the cardiology literature has challenged 
the long established practice of administering 100% oxygen to 
acute angina and myocardial infarction (MI). Yet the first caution 
that administering 100% oxygen may be detrimental to ischemic 
myocardium in the normoxic patient was issued as long ago as 1950 
[32]. In 1969 Bourassa et al [33] reported from experimental studies 
that high flow oxygen can reduce coronary blood flow sufficiently 
to worsen outcomes. More recently McNulty et al [34] provided 
evidence that high flow oxygen reduces coronary artery blood flow 
and confirmed the previously evidence base. Yet the practice of 
using high flow oxygen persisted and was endorsed for years, and 
despite subsequent changes in guidelines [1,12], there is evidence 
that the ritual still persists [35]. Possibly the spotlight on advances in 
pharmacological treatments and surgical interventions was sufficient 
distraction to overlook the growing evidence of concerns regarding 
hyperoxygenation. Moreover a Cochrane Review summarised that 
there is no conclusive evidence to support the use of oxygen therapy 
in acute MI unless hypoxaemia is present, and indicated that further 
clinical trials are urgently needed [36]. A more recent literature 
review concluded that although the level of evidence is insufficient 
there is confirmation that this therapy is ineffective and hazardous 
[37]. A Large RCT is currently underway and due to be reported on 
in 2014 [38].
Confusion regarding whether to administer oxygen routinely 
following ischeamic brain injury (stroke) is also apparent. 
Hypoxia is common immediately following stroke, yet fear of 
exacerbating oxygen free radical injury and an absence of a positive 
benefit regarding whether oxygen effects survival or disability in 
experimental studies [39] has led to controversy. A BMJ editorial 
outlines the fact that clinical guidelines differ across countries and 
are indeed contradictory, having changed over time with apparently 
no justification [40]. Evidence also is conflicting, with some studies 
suggesting that hyperoxia is harmful to the ischeamic brain, whilst 
other studies report a neuroprotective effect, and it has been suggested 
that hyperoxia could indeed narrow the therapeutic window time for 
thrombolysis [38]. So the jury remains out with regards to the use of 
oxygen in stroke although current UK guidelines endorse its use only 
in hypoxic patients [1]. Major on-going clinical trials are anticipated 
to yield results but the consensus appears to be only treat when 
hypoxia is present until further evidence is available [41].
Other Areas of Use
Oxygen is also used routinely in the absence of any robust 
evidence in routine surgery, post-operative care and indeed has been 
found to mask hypoventilation caused by respiratory depression in 
sedated patients [42]. On-going clinical trials continue to seek to 
establish the efficacy of oxygen on mortality, surgical site infections, 
nausea and atelectasis with varying results [43-45]. Likewise on-going 
research is attempting to position the use of hyperoxygenation in 
cluster headache [46] and the use of hyperbaric oxygen for various 
chronic wounds [47-48].
Can oxygen be prescribed to correct hypoxemia in the 
emergency situation whilst avoiding the dangers associated 
with oxygen therapy?
Oxygen therapy should not be prescribed for breathlessness, but 
for hypoxemia; there is no benefit in providing emergency oxygen 
therapy if the patient is already adequately oxygenated. The objective 
is to achieve adequate haemoglobin saturation without over-
oxygenating the patient. The major source of transport for oxygen 
is haemoglobin, and there is a direct relationship between the partial 
pressure of oxygen available and the percentage of haemoglobin that 
will be saturated, represented by the oxyheamoglobin dissociation 
curve. Importantly this curve is not linear but sigmoid in shape: a 
unique property that influences saturation and desaturation (Figure 
1).
Figure 1, point A, illustrates a clinically critical point on the curve; 
this is the point, 8kPa/90% saturation, below which respiratory failure 
is defined. Above this point it can be seen that the curve plateaus 
demonstrating that with further considerable increases in arterial 
oxygen tension (normal PaO2 is 11-13 kPa) relatively small gains in 
saturation will result. Contrary to this if the arterial oxygen tension 
falls below 8 kPa the saturation of the haemoglobin falls rapidly. The 
principles of this curve contribute to the rationale for the titration 
of oxygen to within set ranges according to the presenting clinical 
condition, and illustrate the futility of over-oxygenation.
The patient should, therefore, receive enough oxygen to achieve 
adequate haemoglobin saturation, but should not exceed the 
saturation expected in a normal healthy person. There is consensus 
that oxygen should be prescribed according to a target saturation 
range, and for those who provide and administer the therapy to 
monitor the affect of the therapy and the patient and keep within 
the target saturation range. Indeed the British Thoracic Society 
(BTS) guidelines for emergency oxygen therapy [1] describe this 
recommendation as the essence of the guideline.
The evidence base related to emergency oxygen therapy is rapidly 














Figure 1: The oxyheamoglobin dissociation curve. 
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changing, and newer BTS guidelines are expected in 2015; the clinician 
who prescribes oxygen therapy is beholden to remain cognisant of 
such changes. However key principles are likely to remain constant, 
which are that the aim of therapy is to achieve normal or near-normal 
oxygen saturation for all acutely ill patients apart from those at risk of 
hypercapnic respiratory failure. Target saturation ranges have been 
recommended, and for most patients these are 94 - 98% but for those 
at risk of hypercapnic respiratory failure, 88 - 92% or patient specific 
saturation [1].
Summary
The history of oxygen clearly contributed to the evolvement of 
evidence based medicine and oxygen does and will continue to play 
a central role in contemporary healthcare. To date however it seems 
that empirical knowledge has been overshadowed by erroneous beliefs 
and a culture of using oxygen as a cure for all. Yet empirical evidence 
for oxygen is still lacking. It seems that perhaps oxygen therapy has 
evolved on a trial and error basis founded on the historical perspective. 
A viewpoint further observed in other specialist areas where the 
sluggish application of gathering evidence has undoubtedly inflicted 
further harm and cost lives. Despite this retrospective analysis and 
conjecture however, firm evidence now exists that does not condone 
this haphazard approach or negate current poor practice.
Implementation of changes in the pre-hospital setting may 
be easier as this is protocol driven but practice varies elsewhere. A 
new gold standard of titration must be adopted urgently to prevent 
unnecessary morbidity and mortality. Withholding oxygen from 
a patient presenting with acute shortness of breath, chest pain or 
stroke may seem counter-intuitive or irrational, but the hazardous 
properties of oxygen must be remembered and consideration of 
whether administering oxygen could do more harm than good needs 
to be at the forefront of clinicians’ plan for clinical management.
There is a need to raise awareness of the importance of 
maintaining normal oxygen levels and be aware of the detrimental 
effects of both over and under oxygenation. Clearly more research is 
needed but in the meantime titration to normal or near normal levels 
seems a pragmatic solution.
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